Understanding Pharmaceutical Quality by Design
Top Cited Papers
- 23 May 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in The AAPS Journal
- Vol. 16 (4), 771-783
- https://doi.org/10.1208/s12248-014-9598-3
Abstract
This review further clarifies the concept of pharmaceutical quality by design (QbD) and describes its objectives. QbD elements include the following: (1) a quality target product profile (QTPP) that identifies the critical quality attributes (CQAs) of the drug product; (2) product design and understanding including identification of critical material attributes (CMAs); (3) process design and understanding including identification of critical process parameters (CPPs), linking CMAs and CPPs to CQAs; (4) a control strategy that includes specifications for the drug substance(s), excipient(s), and drug product as well as controls for each step of the manufacturing process; and (5) process capability and continual improvement. QbD tools and studies include prior knowledge, risk assessment, mechanistic models, design of experiments (DoE) and data analysis, and process analytical technology (PAT). As the pharmaceutical industry moves toward the implementation of pharmaceutical QbD, a common terminology, understanding of concepts and expectations are necessary. This understanding will facilitate better communication between those involved in risk-based drug development and drug application review.Keywords
This publication has 18 references indexed in Scilit:
- Orally disintegrating tablet of novel salt of antiepileptic drug: Formulation strategy and evaluationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- Quality-by-Design: An Integrated Process Analytical Technology Approach to Determine the Nucleation and Growth Mechanisms During a Dynamic Pharmaceutical Coprecipitation ProcessJournal of Pharmaceutical Sciences, 2011
- Pharmaceutical Equivalence by Design for Generic Drugs: Modified-Release ProductsPharmaceutical Research, 2011
- Quality-By-Design (QbD): An Integrated Approach for Evaluation of Powder Blending Process Kinetics and Determination of Powder Blending End-pointJournal of Pharmaceutical Sciences, 2009
- Quality-by-design (QbD): an integrated multivariate approach for the component quantification in powder blends.International Journal of Pharmaceutics, 2009
- Quality by design for biopharmaceuticalsNature Biotechnology, 2009
- Quality by Design: Concepts for ANDAsThe AAPS Journal, 2008
- Pharmaceutical Quality by Design: Product and Process Development, Understanding, and ControlPharmaceutical Research, 2008
- Quality by design: Understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box–Behnken design and desirability functionInternational Journal of Pharmaceutics, 2007
- Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredientsInternational Journal of Pharmaceutics, 2002